Lv1
36 积分 2024-02-04 加入
ALK-positive lung cancer: a moving target
3天前
已完结
Identifying optimal ALK inhibitors in first- and second-line treatment of patients with advanced ALK-positive non-small-cell lung cancer: a systematic review and network meta-analysis
5天前
已关闭
Efficacy and Safety of First-Line Treatment Strategies for Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer: A Bayesian Network Meta-Analysis
9天前
已完结
Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer
1个月前
已完结
Breast-Conserving Surgery with or without Irradiation in Early Breast Cancer
2个月前
已完结
Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
2个月前
已完结
Long‐term outcomes of intraoperative radiotherapy for early‐stage breast cancer in China: a multicenter real‐world study
2个月前
已完结
Small cell lung cancer transformation after EGFR-TKIs treatment in lung adenocarcinoma: A case report and literatures review
3个月前
已完结
Holistic View of ALK TKI Resistance in ALK-Positive Anaplastic Large Cell Lymphoma
3个月前
已完结
Response to trametinib in a nonsmall cell lung cancer patient with osimertinib resistance harboring GNAS R201C and R201H mutations: a case report
7个月前
已完结
皖公网安备34019202002308
